Medtech in a Minute: Recalls, Insulet CGM Partnerships, and More
Pressed for time? Here's the medtech news you need most, in one minute or less.
February 21, 2020
Class I Recalls for Abbott and Medtronic
Both Abbott Laboratories and Medtronic faced Class I Recalls last week. Abbott faced a recall of specific lots of its NC Trek RX Coronary Dilatation Catheter. Medtronic’s MiniMed Insulin Pump was the subject of a recall.
Insulet Corners CGM Market with Two High Profile Collaborations
Last week, Insulet revealed it had snared two partnerships that will help it continue its strong momentum in the continuous glucose monitoring (CGM) market. The Billerica, MA-based company signed agreements with both Abbott Laboratories and DexCom.
Grail Keeps Cranking Out Milestones
The Menlo Park, CA-based company said it has initiated PATHFINDER, a multi-center study. PATHFINDER will mark the first time Grail’s test results will be returned to healthcare providers and communicated to participants to help guide appropriate diagnostic workups for more than 50 cancer types.
About the Author
You May Also Like